NRC - NATIONAL RESEARCH CORP


18.03
0.410   2.274%

Share volume: 81,375
Last Updated: 04-17-2026
Business Services/Services – Research, Development, Testing Labs: 0.01%

PREVIOUS CLOSE
CHG
CHG%

$17.62
0.41
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
79%
Profitability 92%
Dept financing 37%
Liquidity 23%
Performance 91%
Company vs Stock growth
vs
Performance
5 Days
5.81%
1 Month
4.16%
3 Months
-17.63%
6 Months
51.13%
1 Year
77.99%
2 Year
-47.02%
Key data
Stock price
$18.03
P/E Ratio 
N/A
DAY RANGE
$17.95 - $18.40
EPS 
$50.00
52 WEEK RANGE
$9.76 - $22.79
52 WEEK CHANGE
$77.99
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
22.746 M
DIVIDEND
$0.12
EX-DIVIDEND DATE
03-28-2025
NEXT EARNINGS DATE
05-06-2025
BETA 
1.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$65,677
AVERAGE 30 VOLUME 
$72,941
Company detail
CEO: Michael D. Hays
Region: US
Website: nrchealth.com
Employees: 490
IPO year: 2013
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

Recent news